We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current IBB market cap is 7.86B. The company's latest EPS is USD -1.4940 and P/E is -84.66.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 53.26M | 50.54M | 65.99M | 64.73M | 58.15M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 348.24M | -223.56M | 2.74B | -1.32B | -92.78M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End March 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 9.38B | 7.28B | 11.02B | 9.41B | 8.89B |
| Total Liabilities | 1.35B | 933.75M | 1.17B | 806.81M | 865.77M |
| Total Equity | 8.03B | 6.34B | 9.85B | 8.61B | 8.03B |
| Market Cap | 7.86B |
| Price to Earnings Ratio | -84.66 |
| Price to Sales Ratio | 135.07 |
| Price to Cash Ratio | 30.85k |
| Price to Book Ratio | 0.98 |
| Dividend Yield | - |
| Shares Outstanding | 62.1M |
| Average Volume (1 week) | 1.8M |
| Average Volume (1 Month) | 1.59M |
| 52 Week Change | -2.65% |
| 52 Week High | 141.16 |
| 52 Week Low | 111.83 |
| Spread (Intraday) | 2.64 (2.07%) |
| Company Name | iShares Biotechnology ETF |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.ishares.com |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
